EUR 10.5
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2018 | 2017 |
---|---|---|---|---|---|---|
Operating Cash Flow | 2.38 Million | 1.08 Million | 1.2 Million | 1.02 Million | -600 Thousand | -440 Thousand |
Net Income | 2.27 Million | -486.13 Thousand | 2.37 Million | 87.95 Thousand | -1.9 Million | 800 Thousand |
Depreciation & Amortization | 1.13 Million | 1.11 Million | 901.43 Thousand | 954.06 Thousand | 670 Thousand | 360 Thousand |
Deferred income taxes | - | - | - | - | 290 Thousand | 20 Thousand |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -1.56 Million | 379.05 Thousand | -1.31 Million | -112.38 Thousand | 600 Thousand | -1.7 Million |
Other non-cash items | 542.06 Thousand | 72.81 Thousand | -753.47 Thousand | 95.28 Thousand | -260 Thousand | 80 Thousand |
Investing Cash Flow | -1.16 Million | -1.23 Million | -417.7 Thousand | -1.07 Million | -2.28 Million | -1.3 Million |
Investments in PPE | -1.16 Million | -1.23 Million | -872.97 Thousand | -1.07 Million | -2.28 Million | -1.34 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | 455.27 Thousand | - | - | 40 Thousand |
Financing Cash Flow | -2.67 Million | -1.78 Million | -1.52 Million | 6.16 Million | 2.93 Million | 3 Million |
Debt repayment | -2.58 Million | -2.16 Million | -1.28 Million | -5.94 Million | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -97.15 Thousand | 379.05 Thousand | -236.73 Thousand | 216.22 Thousand | 2.97 Million | 3 Million |
Accounts receivables | - | - | - | - | -1.48 Million | 600 Thousand |
Accounts payables | - | - | - | - | -2.72 Million | 1.43 Million |
Inventory | - | - | - | - | -2.45 Million | -820 Thousand |
Other working capital | -1.56 Million | 379.05 Thousand | -1.31 Million | -112.38 Thousand | 7.25 Million | -2.91 Million |
Cash at beginning of period | 5.97 Million | 8.41 Million | 9.81 Million | 3.7 Million | 2.8 Million | 1.55 Million |
Cash at end of period | 4.7 Million | 5.97 Million | 8.41 Million | 9.81 Million | 2.85 Million | 2.8 Million |
Capital Expenditure | -1.16 Million | -1.23 Million | -872.97 Thousand | -1.07 Million | -2.28 Million | -1.34 Million |
Effect of forex changes on cash | - | - | - | - | - | -10 Thousand |
Net cash flow / Change in cash | -1.27 Million | -2.43 Million | -1.4 Million | 6.11 Million | 50 Thousand | 1.25 Million |
Free Cash Flow | 1.22 Million | -154.19 Thousand | 333.48 Thousand | -46.42 Thousand | -2.88 Million | -1.78 Million |
Breakdown | 2023 FY | 2022 FY | 2021 FY | 2020 FY | 2018 FY | 2017 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 2.27 Million | -486.13 Thousand | 2.37 Million | 87.95 Thousand | -1.9 Million | 800 Thousand |
Depreciation & Amortization | 1.05 Million | 1.11 Million | 901.43 Thousand | 954.06 Thousand | 670 Thousand | 360 Thousand |
Deferred income taxes | - | - | - | - | 290 Thousand | 20 Thousand |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -1.56 Million | 379.05 Thousand | -1.31 Million | -112.38 Thousand | 600 Thousand | -1.7 Million |
Other non-cash items | 620.44 Thousand | 72.81 Thousand | -753.47 Thousand | 95.28 Thousand | -260 Thousand | 80 Thousand |
Investing Cash Flow | -1.16 Million | -1.23 Million | -417.7 Thousand | -1.07 Million | -2.28 Million | -1.3 Million |
Investments in PPE | -1.16 Million | -1.23 Million | -872.97 Thousand | -1.07 Million | -2.28 Million | -1.34 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | 455.27 Thousand | - | - | 40 Thousand |
Financing Cash Flow | -2.67 Million | -1.78 Million | -1.52 Million | 6.16 Million | 2.93 Million | 3 Million |
Debt repayment | -2.58 Million | -2.16 Million | -1.28 Million | -5.94 Million | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -97.15 Thousand | 379.05 Thousand | -236.73 Thousand | 216.22 Thousand | 2.97 Million | 3 Million |
Accounts receivables | - | - | - | - | -1.48 Million | 600 Thousand |
Accounts payables | - | - | - | - | -2.72 Million | 1.43 Million |
Inventory | - | - | - | - | -2.45 Million | -820 Thousand |
Other working capital | -1.56 Million | 379.05 Thousand | -1.31 Million | -112.38 Thousand | 7.25 Million | -2.91 Million |
Cash at beginning of period | 5.97 Million | 8.41 Million | 9.81 Million | 3.7 Million | 2.8 Million | 1.55 Million |
Cash at end of period | 4.7 Million | 5.97 Million | 8.41 Million | 9.81 Million | 2.85 Million | 2.8 Million |
Capital Expenditure | -1.16 Million | -1.23 Million | -872.97 Thousand | -1.07 Million | -2.28 Million | -1.34 Million |
Effect of forex changes on cash | - | - | - | - | - | -10 Thousand |
Net cash flow / Change in cash | -1.27 Million | -2.43 Million | -1.4 Million | 6.11 Million | 50 Thousand | 1.25 Million |
Free Cash Flow | 1.22 Million | -154.19 Thousand | 333.48 Thousand | -46.42 Thousand | -2.88 Million | -1.78 Million |
KREBSBIO
002688
KUMPFIN
HKXCY
S68
300421